Literature DB >> 29932035

Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).

Evandro Fei Fang1, Lynn Froetscher1, Morten Scheibye-Knudsen1, Vilhelm A Bohr1, Jack Ho Wong2, Tzi Bun Ng2.   

Abstract

Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  DNA damage; Momordica charantia; anticancer; apoptosis; bitter melon; medicinal applications.

Mesh:

Substances:

Year:  2019        PMID: 29932035      PMCID: PMC6486373          DOI: 10.2174/1389203719666180622095800

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  4 in total

1.  Cucurbitane-Type Triterpenoids from the Vines of Momordica charantia and Their Anti-inflammatory Activities.

Authors:  Hung-Tse Huang; Li-Jie Zhang; Hui-Chi Huang; Syh-Yuan Hwang; Chia-Lun Wu; Yu-Chi Lin; Chia-Ching Liaw; Yung-Yi Cheng; Susan L Morris-Natschke; Chung-Yi Huang; Kuo-Hsiung Lee; Yao-Haur Kuo
Journal:  J Nat Prod       Date:  2020-05-01       Impact factor: 4.050

Review 2.  Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy.

Authors:  Subhayan Sur; Ratna B Ray
Journal:  Cancers (Basel)       Date:  2020-07-27       Impact factor: 6.639

3.  Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.

Authors:  Meng Yang; Qingqiong Luo; Xu Chen; Fuxiang Chen
Journal:  J Nanobiotechnology       Date:  2021-08-28       Impact factor: 10.435

4.  Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling.

Authors:  Subhayan Sur; Robert Steele; T Scott Isbell; Kalyan Nagulapalli Venkata; Mostafa E Rateb; Ratna B Ray
Journal:  Cancers (Basel)       Date:  2021-03-21       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.